This subpart sets forth the requirements relating to the following:
(a)
Drug utilization management programs, quality assurance measures and systems, and medication therapy management programs (MTMP) for Part D sponsors.
(b)
Consumer satisfaction surveys of Part D plans.
(c)
Electronic prescription drug programs for prescribers, dispensers, and Part D sponsors.
(d)
Quality improvement organization (QIO) activities.
(e)
Compliance deemed on the basis of accreditation.
(f)
Accreditation organizations.
(g)
Procedures for the approval of accreditation
organizations as a basis for deeming compliance.
[70 FR 4525, Jan. 28, 2005, as amended at 70 FR 67593, Nov. 7, 2005]